Protocol Summary
Protocol No.
164140 (HCI; RADVAX)
Principal Investigator
Hu-Lieskovan, Siwen
Phase
II
Age Group
Adult
ClinicalTrials.Gov
NCT03646617 (Click to jump to clinicaltrials.gov)
Title
RADVAX: Randomized Phase II Trial Of Ipilimumab And Nivolumab With Or Without Hypofractionated Radiotherapy In Patients With Metastatic Melanoma
Objective
Applicable Disease Sites
Melanoma
Participating Institutions
Huntsman Cancer Institute
Status
Open
Clinical trials search powered by Forte Research Systems
